Rifaximin‐altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials

AIMS: Rifaximin (RFX), a non‐systemic antibiotic, improves liver/neuropsychological functions in patients with hepatic encephalopathy (HE). We aimed to investigate the clinical profiles associated with gut bacterial loads using exploratory data analysis and the effects of RFX on the gut microbiota o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Takumi, Suzuki, Fumitaka, Imamura, Masatoshi, Murashima, Naoya, Yanase, Mikio, Mine, Tetsuya, Fujisawa, Masaki, Sato, Ikuya, Yoshiji, Hitoshi, Okita, Kiwamu, Suzuki, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849579/
https://www.ncbi.nlm.nih.gov/pubmed/30589492
http://dx.doi.org/10.1111/hepr.13300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849579/
https://www.ncbi.nlm.nih.gov/pubmed/30589492
http://dx.doi.org/10.1111/hepr.13300

Ejemplares similares